Milestone Pharmaceuticals Inc. Common Shares Stock Prediction
AI-powered sentiment analysis and prediction trends for MIST, updated each market day.
MIST AI Sentiment
AI predicts Milestone Pharmaceuticals Inc. Common Shares stock is likely to decrease over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Milestone Pharmaceuticals Inc. Common Shares
Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.
Sector
Exchange
Market Cap
$236,511,226
Cap Tier
Employees
38
Headquarters
MONTREAL, A8
Listed Since
May 9, 2019
Website
MIST Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
MIST Volatility
Milestone Pharmaceuticals Inc. Common Shares has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
